Related Experiment Video

Updated: Jun 25, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Cinnamon extract suppresses tumor progression by modulating angiogenesis and the effector function of CD8+ T cells

Ho-Keun Kwon1, Won Kyung Jeon2, Ji-Sun Hwang1

  • 1Department of Life Sciences, Gwangju Institute of Science and Technology (GIST), 1 Oryong-dong, Puk-ku, Gwangju 500-712, Republic of Korea.

Cancer Letters
|February 11, 2009
PubMed

Insights

Cinnamon extract shows potential as an anti-tumor medicine. It inhibits melanoma tumor progression and enhances CD8(+) T cell activity, offering a natural approach to cancer treatment.

Area of Science:

  • Pharmacology
  • Immunology
  • Oncology

Background:

  • Cinnamon is a widely used herbal medicine with known bioactive effects.
  • Limited evidence exists regarding cinnamon's anti-tumor properties.
  • Melanoma remains a significant health concern requiring novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential anti-tumor effects of cinnamon.
  • To evaluate cinnamon's impact on melanoma progression and immune cell activity.
  • To explore cinnamon as a complementary or alternative cancer treatment.

Main Methods:

  • In vitro studies using melanoma cell lines.
  • In vivo experimental melanoma models.
  • Analysis of pro-angiogenic factors and tumor progression regulators.
  • Assessment of CD8(+) T cell activity, including cytolytic molecule levels and cytotoxic activity.

Main Results:

  • Cinnamon treatment significantly inhibited pro-angiogenic factors and tumor progression regulators in melanoma.
  • Cinnamon enhanced the anti-tumor activities of CD8(+) T cells.
  • Increased levels of cytolytic molecules and enhanced cytotoxic activity of T cells were observed.

Conclusions:

  • Cinnamon extract demonstrates significant anti-tumor potential.
  • Cinnamon may serve as an effective agent against melanoma by inhibiting tumor growth and boosting anti-tumor immunity.
  • Further research into cinnamon as an alternative cancer therapy is warranted.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...